Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Auto, IT stocks drag markets
Wed, 4 May 11:30 am

Indian stock markets continue to flounder in the red on profit booking in heavy weights over the last two hours of trade. Stocks from the auto and IT space are trading weak while stocks from the oil & gas and FMCG space are trading firm.

The BSE-Sensex is down by 136 points while NSE-Nifty is trading 50 points below the dotted line. BSE Midcap index is down by 0.8% while BSE Small cap index is trading 0.7% below yesterday's closing. The rupee is trading at 44.53 to the US dollar.

FMCG stocks are trading mixed with stocks like Hindustan Unilever and Gillette India witnessing buying interest while Camlin and Godrej Consumers are trading in the red. Dabur India has gotten into an agreement with Ajanta Pharma to acquire their energizer brand "30-Plus". It may be noted that "30-Plus" was launched in 1990 as an herbal energizer capsule for thirty-plus males in India. The brand promoted by the likes of Jeetendra turned out to be an instant hit among the Indian consumers.

Dabur's latest announcement is in line with the company's intention to focus on healthcare business. This transaction will help the FMCG company establish its presence in the OTC (over the counter) health care market. As per the management, it will provide them synergy benefits and enable them to suit the demands both domestically and internationally. They are in talks with a few more companies to increase their product portfolio in the OTC segment. Dabur's turnover last year was Rs 41 bn of which Rs 10 bn were contributed by the OTC segment.

Engineering stocks are trading mixed with Finolex Cables and Punj Lloyd trading firm while Lakshmi Machine and Emco Ltd are trading weak. Sintex Industries declared its FY11 results. The company's top line for the year grew by a strong 35% YoY. This growth was on the back of the company's plastic and textile divisions. While the plastic division posted a robust growth of 36% YoY, textile business grew by 26% YoY. Sales of the plastic division was led by the sub segment of building material which grew by 51% YoY during the year and custom molding which grew by 26% YoY during the year. Operating margin of the company grew by 2% to stand at 18.2%. This was due to fall in staff costs and other expenditure (as a percentage of sales). The growth would have been sharper but for a sharp increase in raw material costs (as a percentage of sales). Net profit grew by 39.8% YoY. This was slower than operating profit growth and comes on the back of fall in other income, increase in interest costs and rise in effective tax rate.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Auto, IT stocks drag markets". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.